Five drugmakers have issued recent refund notices to 340B covered entities for drug overcharges. In letters posted on the website [...] …
Year: 2024
A House oversight hearing this week added to the growing debate over the 340B program’s future as federal lawmakers continue [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Minnesota became the 7th state to enact a law to protect distribution of 340B drugs through contract pharmacies when the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
New York lawmakers are expected to leave Albany this week without passing legislation that would bar drug manufacturers and pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Novartis recently filed the second lawsuit that seeks to block implementation and enforcement of a recently enacted Mississippi law [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Bristol Myers Squibb (BMS) announced updates to its conditions on pharmaceutical sales involving contract pharmacies, requiring registered sites to be [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Swedish biopharmaceutical company Sobi announced this week that beginning July 1 it will implement 340B contract pharmacy restrictions, making the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
TIP: Don’t assume your contract pricing is correct on every account just because it’s correct on one account.
340B hospitals need new transparency requirements and program eligibility rules to ensure the sustainability of the program, Republican lawmakers said [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key House subcommittee oversight hearing today on the 340B program will include a witness who previously said Congress should [...] …
